B of A Securities Maintains Neutral on Hims & Hers Health, Raises Price Target to $36
B of A Securities analyst Allen Lutz maintains Hims & Hers Health (NYSE: HIMS ) with a Neutral and raises the price target from $25 to $36.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.